Skip to main content
logo
Bio-Gene Technology Limited (ASX:BGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0230
+0.0010 (4.55%)
Aug 5, 2026, 3:06 PM AEST

Bio-Gene Technology Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
--0.020.150.450.06
Revenue Growth
---87.72%-66.52%611.91%-49.01%
Gross Profit
0.08-0.25-0.3-0.120.22-0.06
Operating Income
-2.54-2.62-2.5-3.18-2.97-2.43
Net Income
-2.52-2.58-2.41-3.1-2.91-2.4
Earnings Per Share
-0.01-0.01-0.01-0.02-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
1.081.142.212.996.343.93
Total Debt
------
Net Cash (Debt)
1.081.142.212.996.343.93
Net Cash Growth
-5.04%-48.48%-26.11%-52.84%61.24%-28.62%
Net Cash Per Share
0.000.010.010.020.040.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-2.62-2.54-2.75-3.28-1.99-1.83
Capital Expenditures
---0.01--0.01-0
Free Cash Flow
-2.62-2.54-2.76-3.28-2-1.83
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
----79.57%49.83%-90.03%
Operating Margin
---13625.67%-2132.08%-665.67%-3887.62%
Pretax Margin
---13150.54%-2074.48%-653.81%-3827.29%
Profit Margin
---13150.54%-2074.48%-653.81%-3827.29%
FCF Margin
---15065.19%-2195.48%-448.66%-2920.54%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
--538.5892.9951.93417.15